RdRP-IN-6
Product Specifications
UNSPSC Description
RdRP-IN-6 (compound 27) inhibits RNA dependent-RNA polymerase (RdRp) with an IC90 value of 14.1 μM. RdRP-IN-6 can be used for research on antiviral and anticancer[1].
Target Antigen
DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/rdrp-in-6.html
Solubility
10 mM in DMSO
Smiles
O=[P@@](N[C@H](C(OCC(CC)CC)=O)C)(OC[C@@H]1[C@@H](O[Si](C(C)(C)C)(C)C)[C@H](O[Si](C(C)(C)C)(C)C)[C@](C2=CNN=N2)(C3=CC=C4C(N)=NC=NN34)C1)OC5=CC=CC=C5
Molecular Weight
871.16
References & Citations
[1]Cardoza S, et al. Multistep Synthesis of Analogues of Remdesivir: Incorporating Heterocycles at the C-1' Position. J Org Chem. 2023 Jul 7;88(13):9105-9122.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-154989/RdRP-IN-6-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-154989/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items